Key Highlights
- First-quarter adjusted EPS reached $7.23, surpassing the anticipated $6.58, while revenue totaled $111.7 billion compared to the expected $109.4 billion.
- Shares climbed 5.7% to $342 during Tuesday’s premarket session.
- Annual adjusted EPS forecast increased to above $18.25, raised from the January projection of $17.75.
- Medical care ratio enhanced to 83.9% in Q1 2026, showing progress from 84.8% recorded in the prior year.
- The healthcare giant commits a minimum of $1.5 billion toward artificial intelligence initiatives to counter a $6 billion Medicare reimbursement challenge.
UnitedHealth Group delivered impressive first-quarter performance, surpassing Wall Street projections for both earnings and revenue while enhancing its annual forecast. These developments emerge as the healthcare leader pursues its transformation strategy under CEO Stephen Hemsley, who resumed leadership responsibilities last May.
Adjusted earnings for the first quarter reached $7.23 per share, significantly exceeding the consensus projection of $6.58. Revenue achieved $111.7 billion, surpassing analyst expectations of $109.4 billion. The quarter generated net income of $6.28 billion, translating to $6.90 per share.
Shares advanced 5.7% to $342 during Tuesday’s premarket trading session.
UnitedHealth Group Incorporated, UNH
The company elevated its full-year adjusted EPS forecast to exceed $18.25, representing an increase from the $17.75 outlook provided in January. CFO Wayne DeVeydt informed Barron’s that management would probably defer additional forecast adjustments until after second-quarter results. “We’d like to just see a few more months get under our belt,” he explained.
UnitedHealthcare segment revenues expanded to $86.3 billion during the quarter, advancing from $84.6 billion in the first quarter of 2025. Operating margin reached 6.6%, improving from 6.2% in the comparable period.
Medical Expense Management Demonstrates Progress
Among the most encouraging indicators in the quarterly report was the medical care ratio — representing the proportion of premium revenue allocated to medical expenses. This metric declined to 83.9% in Q1 2026 from 84.8% recorded in Q1 2025. The improvement carries particular significance following the ratio’s spike to 91.5% in Q4 2025.
Management credited the enhancement to disciplined cost management practices and positive reserve development. Higher utilization rates and elevated unit costs continued to partially counterbalance these gains.
UnitedHealth has strategically withdrawn from underperforming markets, encompassing individual ACA plans and select Medicare Advantage counties. This strategic repositioning resulted in membership declining from 49.8 million at the conclusion of 2025 to 49.1 million in Q1 2026. Medicare Advantage enrollment decreased by 965,000 members throughout the quarter.
Optum Performance and Technology Investments
Optum Health, which faced challenges during much of 2025, generated $1.3 billion in adjusted operating earnings during Q1. DeVeydt characterized this as a “very good start” relative to the full-year target exceeding $1.6 billion. “We view this as a multiyear journey,” he stated.
UnitedHealth is allocating a minimum of $1.5 billion toward artificial intelligence capabilities during the current year. Company leadership indicates these technology investments are instrumental in addressing a $6 billion challenge stemming from previous Medicare reimbursement modifications. DeVeydt characterized the return period for AI projects as “very short.”
Earlier this month, Medicare administrators confirmed an average 2.48% reimbursement rate increase for insurance providers in the coming year. UNH shares had already appreciated 9% following that announcement. DeVeydt recognized the increase “didn’t fully address” prevailing medical cost trends, confirming that benefit adjustments remain necessary for 2026.
Morgan Stanley elevated UNH to “top pick” status on April 16, pointing to expectations for a “string of clean quarters” subsequent to the improved Medicare rate disclosure.
UnitedHealthcare’s employer self-funded business sector helped compensate for membership declines, while the insurer’s OptumRx pharmacy benefit division additionally supported overall revenue expansion.
